Teleconference and Public Meeting of the Chronic Hazard Advisory Panel on Phthalates and Phthalate Substitutes, 2276-2277 [2012-645]

Download as PDF srobinson on DSK4SPTVN1PROD with NOTICES 2276 Federal Register / Vol. 77, No. 10 / Tuesday, January 17, 2012 / Notices Title: Patent and Trademark Resource Centers Metrics. Form Number(s): N/A. Agency Approval Number: 0651– 00xx. Type of Request: New information collection. Burden: 162 hours annually. Number of Respondents: 324 responses per year (81 libraries reporting their metrics quarterly). Avg. Hours Per Response: The USPTO estimates that it will take the Patent and Trademark Resource Center (PTRC) librarians approximately 30 minutes (0.50 hours) to submit the information in this collection, including the time to gather the necessary information, prepare the worksheet, and submit the completed request to the USPTO. Needs and Uses: The USPTO has developed an electronic worksheet to gather the metrics required under 35 U.S.C. 2(a)(2). The PTRCs will use this electronic worksheet to provide quarterly metrics to the USPTO concerning the public’s use of the member library’s patent and trademark services and the member library’s public outreach efforts. The USPTO will use the information in this collection to determine how to more effectively train the PTRC staff and to determine what types of new and different services the PTRCs should provide to the public in the future. Affected Public: Non-profit organizations. Frequency: Quarterly. Respondent’s Obligation: Required to obtain or retain benefits. OMB Desk Officer: Nicholas A. Fraser, email: Nicholas_A._Fraser@omb. eop.gov. Once submitted, the request will be publicly available in electronic format through the Information Collection Review page at https://www.reginfo.gov. Paper copies can be obtained by: • Email: InformationCollection@ uspto.gov. Include ‘‘0651–00xx Patent and Trademark Resource Centers Metrics copy request’’ in the subject line of the message. • Mail: Susan K. Fawcett, Records Officer, Office of the Chief Information Officer, United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313–1450. Written comments and recommendations for the proposed information collection should be sent on or before February 16, 2012 to Nicholas A. Fraser, OMB Desk Officer, via email to Nicholas_A._Fraser@omb.eop.gov, or by fax to (202) 395–5167, marked to the attention of Nicholas A. Fraser. VerDate Mar<15>2010 16:12 Jan 13, 2012 Jkt 226001 Dated: January 11, 2012. Susan K. Fawcett, Records Officer, USPTO, Office of the Chief Information Officer. [FR Doc. 2012–720 Filed 1–13–12; 8:45 am] BILLING CODE 3510–16–P CONSUMER PRODUCT SAFETY COMMISSION Teleconference and Public Meeting of the Chronic Hazard Advisory Panel on Phthalates and Phthalate Substitutes Consumer Product Safety Commission. ACTION: Notice of meetings. AGENCY: The Consumer Product Safety Commission (‘‘CPSC’’ or ‘‘Commission’’) is announcing a teleconference and the seventh meeting of the Chronic Hazard Advisory Panel (CHAP) on phthalates and phthalate substitutes. The Commission appointed this CHAP on April 14, 2010, to study the effects on children’s health of all phthalates and phthalate alternatives, as used in children’s toys and child care articles, pursuant to section 108 of the Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 110–314). The CHAP will discuss its progress toward completing its analysis of potential risks from phthalates and phthalate substitutes. DATES: The teleconference will take place from 11 a.m. to 1 p.m. EST (15:00 to 17:00 GMT) on Wednesday, February 1, 2012. Interested members of the public may listen to the CHAP’s discussion. Members of the public will not have the opportunity to ask questions, comment, or otherwise participate in the teleconference. Interested parties should contact the CPSC project manager, Michael Babich, by email (mbabich@cpsc.gov) for call-in instructions no later than Monday, January 30, 2012. An additional public meeting will be held on Wednesday, February 15 through Friday, February 17, 2012. The meeting will begin at approximately 9 a.m. each day. It will end at approximately 5 p.m. on Wednesday and Thursday, and at approximately 2 p.m. on Friday. There will not be any opportunity for public participation at this meeting. Registration and Webcast: No registration is required for the teleconference on February 1, 2012. Please follow the instructions above regarding the call-in instructions for the teleconference. Members of the public who wish to attend the February 15–17 public meeting in person may register on the day of the meeting. This meeting SUMMARY: PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 will also be available live via webcast at: https://www.cpsc.gov/Webcast. Registration is not necessary to view the webcast. ADDRESSES: The meeting will be held in the fourth floor hearing room at the Commission’s offices at 4330 East West Highway, Bethesda, MD. FOR FURTHER INFORMATION CONTACT: Michael Babich, Directorate for Health Sciences, Consumer Product Safety Commission, Bethesda, MD 20814; telephone (301) 504–7253; email mbabich@cpsc.gov. SUPPLEMENTARY INFORMATION: Section 108 of the CPSIA permanently prohibits the sale of any ‘‘children’s toy or child care article’’ containing more than 0.1 percent of each of three specified phthalates: Di- (2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), and benzyl butyl phthalate (BBP). Section 108 of the CPSIA also prohibits, on an interim basis, the sale of any ‘‘children’s toy that can be placed in a child’s mouth’’ or ‘‘child care article’’ containing more than 0.1 percent of each of three additional phthalates: diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-octyl phthalate (DnOP). Moreover, section 108 of the CPSIA requires the Commission to convene a CHAP ‘‘to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles.’’ The CPSIA requires the CHAP to complete an examination of the full range of phthalates that are used in products for children and: • Examine all of the potential health effects (including endocrine-disrupting effects) of the full range of phthalates; • Consider the potential health effects of each of these phthalates, both in isolation, and in combination with other phthalates; • Examine the likely levels of children’s, pregnant women’s, and others’ exposure to phthalates, based upon a reasonable estimation of normal and foreseeable use and abuse of such products; • Consider the cumulative effect of total exposure to phthalates, both from children’s products and from other sources, such as personal care products; • Review all relevant data, including the most recent, best-available, peerreviewed, scientific studies of these phthalates and phthalate alternatives that employ objective data-collection practices or employ other objective methods; • Consider the health effects of phthalates not only from ingestion, but E:\FR\FM\17JAN1.SGM 17JAN1 Federal Register / Vol. 77, No. 10 / Tuesday, January 17, 2012 / Notices also as a result of dermal, hand-tomouth, or other exposure; • Consider the level at which there is a reasonable certainty of no harm to children, pregnant women, or other susceptible individuals and their offspring, considering the best available science, and using sufficient safety factors to account for uncertainties regarding exposure and susceptibility of children, pregnant women, and other potentially susceptible individuals; and • Consider possible similar health effects of phthalate alternatives used in children’s toys and child care articles. The CPSIA contemplates completion of the CHAP’s examination within 18 months of the panel’s appointment on April 14, 2010. The CHAP has an additional 6 months to complete its final report to the Commission. The CHAP must review prior work on phthalates by the Commission, but it is not to be considered determinative because the CHAP’s examination must be conducted de novo. The CHAP must make recommendations to the Commission regarding any phthalates (or combinations of phthalates), in addition to those identified in section 108 of the CPSIA, or phthalate alternatives that the panel determines should be prohibited from use in children’s toys or child care articles, or otherwise restricted. The CHAP members were selected by the Commission from scientists nominated by the National Academy of Sciences. See 15 U.S.C. 2077, 2030(b). The CHAP met previously in April, July, and December 2010, and in March, July, and November 2011, at the CPSC’s offices in Bethesda, MD, and by teleconference in November 2010, September 2011, and December 2011. The CHAP heard testimony from interested parties at the July 2010, and November 2011 meetings. The February 2012 teleconference and public meeting will include discussion of the CHAP’s progress in preparing a final report. There will not be any opportunity for public comment during the February 2012 teleconference or the public meeting. Dated: January 11, 2012. Todd A. Stevenson, Secretary, Consumer Product Safety Commission. srobinson on DSK4SPTVN1PROD with NOTICES [FR Doc. 2012–645 Filed 1–13–12; 8:45 am] BILLING CODE 6355–01–P 8:30 a.m. .......... 9 a.m. ............... 10:30 a.m. ........ 10:45 a.m. ........ 12 p.m. ............. 1 p.m. ............... VerDate Mar<15>2010 CORPORATION FOR NATIONAL AND COMMUNITY SERVICE Sunshine Act Meeting Jkt 226001 Dated: January 11, 2012. Valerie E. Green, General Counsel. [FR Doc. 2012–826 Filed 1–12–12; 4:15 pm] The National Civilian Community Corps Advisory Board gives notice of the following meeting: BILLING CODE 6050–$$–P Tuesday, February 14, 2012, 2 p.m.–3:30 p.m. DEPARTMENT OF DEFENSE Conference room #8312, 8th floor, Corporation for National and Community Service Headquarters, 1201 New York Avenue NW. Washington, DC 20525 Federal Advisory Committee; Defense Intelligence Agency (DIA) Advisory Board; Closed Meeting DATE AND TIME: PLACE: This meeting is available to the public through the following toll-free call-in number: (888) 455–7057 conference call access code number NCCC. Any interested member of the public may call this number and listen to the meeting. Callers can expect to incur charges for calls they initiate over wireless lines, and the Corporation will not refund any incurred charges. Callers will incur no charge for calls they initiate over land-line connections to the toll-free telephone number. Replays are generally available one hour after a call ends. The toll-free phone number for the replay is (203) 369–1895. The end replay date: March 14, 2012, 11:59 p.m. (CT). CALL-IN INFORMATION: STATUS: Open. Matters To Be Considered I. Meeting Convenes II. Approval of Minutes III. Director’s Report: IV. Area Reports: • Projects and Partnerships • Member Development • Policy and Operations V. Public Comment Anyone who needs an interpreter or other accommodation should notify the Corporation’s contact person by 5 p.m. Wednesday, January 27, 2012. ACCOMMODATIONS: FOR FURTHER INFORMATION CONTACT: Erma Hodge, NCCC, Corporation for National and Community Service, 9th Floor, Room 9802B, 1201 New York Avenue NW., Washington, DC 20525. Phone (202) 606–6696. Fax (202) 606– 3459. TTY: (800) 833–3722. Email: ehodge@cns.gov. Convene Advisory Board Meeting and Administrative Business. Subcommittee Business Break Classified Briefings .................................................................... Lunch Briefings and Discussion ........................................................... 16:12 Jan 13, 2012 2277 PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 Office of the Secretary AGENCY: DIA, Department of Defense (DoD). ACTION: Meeting notice. Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C. Appendix 2 (2001)), the Government in the Sunshine Act of 1976 (5 U.S C. 552b), and 41 CFR 102– 3.10, DoD hereby announces that the DIA Advisory Board will meet on February 24, 2012. The meeting is closed to the public. The meetings necessarily include discussions of classified information relating to DIA’s intelligence operations including its support to current operations. DATES: The meeting will be held on February 24, 2012 (from 8:30 a.m. to 4 p.m.). ADDRESSES: The meeting will be held at Bolling Air Force Base. FOR FURTHER INFORMATION CONTACT: Mr. Mark Harrison, (703) 697–5102, Alternate Designated Federal Official, DIA Office for Congressional and Public Affairs, Pentagon 1A874, Washington, DC 20340–5100. Committee’s Designated Federal Official: Mr. William Caniano, (703) 614–4774, DIA Office for Congressional and Public Affairs, Pentagon 1A874, Washington, DC 20340–5100. William. Caniano@dodiis.mil. SUPPLEMENTARY INFORMATION: SUMMARY: Purpose of the Meeting For the Advisory Board to discuss DIA operations and capabilities in support of current intelligence operations. Agenda February 24, 2012 Mr. William Caniano, Designated Federal Official, Mrs. Mary Margaret Graham, Chairman. DIA Personnel. LTG Burgess, Director, DIA. E:\FR\FM\17JAN1.SGM 17JAN1

Agencies

Consumer Product Safety Commission

[Federal Register Volume 77, Number 10 (Tuesday, January 17, 2012)]
[Notices]
[Pages 2276-2277]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-645]


=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION


Teleconference and Public Meeting of the Chronic Hazard Advisory 
Panel on Phthalates and Phthalate Substitutes

AGENCY: Consumer Product Safety Commission.

ACTION: Notice of meetings.

-----------------------------------------------------------------------

SUMMARY: The Consumer Product Safety Commission (``CPSC'' or 
``Commission'') is announcing a teleconference and the seventh meeting 
of the Chronic Hazard Advisory Panel (CHAP) on phthalates and phthalate 
substitutes. The Commission appointed this CHAP on April 14, 2010, to 
study the effects on children's health of all phthalates and phthalate 
alternatives, as used in children's toys and child care articles, 
pursuant to section 108 of the Consumer Product Safety Improvement Act 
of 2008 (CPSIA) (Pub. L. 110-314). The CHAP will discuss its progress 
toward completing its analysis of potential risks from phthalates and 
phthalate substitutes.

DATES: The teleconference will take place from 11 a.m. to 1 p.m. EST 
(15:00 to 17:00 GMT) on Wednesday, February 1, 2012. Interested members 
of the public may listen to the CHAP's discussion. Members of the 
public will not have the opportunity to ask questions, comment, or 
otherwise participate in the teleconference. Interested parties should 
contact the CPSC project manager, Michael Babich, by email 
(mbabich@cpsc.gov) for call-in instructions no later than Monday, 
January 30, 2012. An additional public meeting will be held on 
Wednesday, February 15 through Friday, February 17, 2012. The meeting 
will begin at approximately 9 a.m. each day. It will end at 
approximately 5 p.m. on Wednesday and Thursday, and at approximately 2 
p.m. on Friday. There will not be any opportunity for public 
participation at this meeting.
    Registration and Webcast: No registration is required for the 
teleconference on February 1, 2012. Please follow the instructions 
above regarding the call-in instructions for the teleconference. 
Members of the public who wish to attend the February 15-17 public 
meeting in person may register on the day of the meeting. This meeting 
will also be available live via webcast at: https://www.cpsc.gov/Webcast. Registration is not necessary to view the webcast.

ADDRESSES: The meeting will be held in the fourth floor hearing room at 
the Commission's offices at 4330 East West Highway, Bethesda, MD.

FOR FURTHER INFORMATION CONTACT: Michael Babich, Directorate for Health 
Sciences, Consumer Product Safety Commission, Bethesda, MD 20814; 
telephone (301) 504-7253; email mbabich@cpsc.gov.

SUPPLEMENTARY INFORMATION: Section 108 of the CPSIA permanently 
prohibits the sale of any ``children's toy or child care article'' 
containing more than 0.1 percent of each of three specified phthalates: 
Di- (2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), and 
benzyl butyl phthalate (BBP). Section 108 of the CPSIA also prohibits, 
on an interim basis, the sale of any ``children's toy that can be 
placed in a child's mouth'' or ``child care article'' containing more 
than 0.1 percent of each of three additional phthalates: diisononyl 
phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-octyl phthalate 
(DnOP).
    Moreover, section 108 of the CPSIA requires the Commission to 
convene a CHAP ``to study the effects on children's health of all 
phthalates and phthalate alternatives as used in children's toys and 
child care articles.'' The CPSIA requires the CHAP to complete an 
examination of the full range of phthalates that are used in products 
for children and:
     Examine all of the potential health effects (including 
endocrine-disrupting effects) of the full range of phthalates;
     Consider the potential health effects of each of these 
phthalates, both in isolation, and in combination with other 
phthalates;
     Examine the likely levels of children's, pregnant women's, 
and others' exposure to phthalates, based upon a reasonable estimation 
of normal and foreseeable use and abuse of such products;
     Consider the cumulative effect of total exposure to 
phthalates, both from children's products and from other sources, such 
as personal care products;
     Review all relevant data, including the most recent, best-
available, peer-reviewed, scientific studies of these phthalates and 
phthalate alternatives that employ objective data-collection practices 
or employ other objective methods;
     Consider the health effects of phthalates not only from 
ingestion, but

[[Page 2277]]

also as a result of dermal, hand-to-mouth, or other exposure;
     Consider the level at which there is a reasonable 
certainty of no harm to children, pregnant women, or other susceptible 
individuals and their offspring, considering the best available 
science, and using sufficient safety factors to account for 
uncertainties regarding exposure and susceptibility of children, 
pregnant women, and other potentially susceptible individuals; and
     Consider possible similar health effects of phthalate 
alternatives used in children's toys and child care articles.
    The CPSIA contemplates completion of the CHAP's examination within 
18 months of the panel's appointment on April 14, 2010. The CHAP has an 
additional 6 months to complete its final report to the Commission. The 
CHAP must review prior work on phthalates by the Commission, but it is 
not to be considered determinative because the CHAP's examination must 
be conducted de novo.
    The CHAP must make recommendations to the Commission regarding any 
phthalates (or combinations of phthalates), in addition to those 
identified in section 108 of the CPSIA, or phthalate alternatives that 
the panel determines should be prohibited from use in children's toys 
or child care articles, or otherwise restricted. The CHAP members were 
selected by the Commission from scientists nominated by the National 
Academy of Sciences. See 15 U.S.C. 2077, 2030(b).
    The CHAP met previously in April, July, and December 2010, and in 
March, July, and November 2011, at the CPSC's offices in Bethesda, MD, 
and by teleconference in November 2010, September 2011, and December 
2011. The CHAP heard testimony from interested parties at the July 
2010, and November 2011 meetings. The February 2012 teleconference and 
public meeting will include discussion of the CHAP's progress in 
preparing a final report. There will not be any opportunity for public 
comment during the February 2012 teleconference or the public meeting.

    Dated: January 11, 2012.
Todd A. Stevenson,
Secretary, Consumer Product Safety Commission.
[FR Doc. 2012-645 Filed 1-13-12; 8:45 am]
BILLING CODE 6355-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.